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Abstract
Objectives: Pyocyanin is blue pigment redox active, secondary me-
tabolites produced by P. aeruginosa. The present study investigated 
the bioactivity of pyocyanin against certain types of bacteria and fungi 
causing human infections
Methods: A total of 23 clinical isolates of P. aeruginosa were collec-
ted from patients admitted to the General Baqubah Hospital during 
the period from November 2016 through May 2017. All isolates were 
cultured on Pseudomonas agar and confirmed by biochemical tests as 
P. aeruginosa. Pyocyanin extraction was done by chloroform method 
and concentration was determined by multiplying the optical density 
at 520 nm by 17.072 expressed as µg/ml. Biological activity of pyo-
cyanin was determined by well diffusion procedure.
Results: According to the source of P. aeruginosa, the most tested 
isolates were from ear infection (30%) followed by wounds (22%), 
burns (17%), urine (13%) and both stool and diabetic leg ulcer (9%). 
Antimicrobial resistant of P. aeruginosa isolates were the following: 
19 (82.6 %) to piperacillin, followed by 10 (43.5%) to aztreonem, 
8 (34.8%) to meropenem, 6 (26.1%) to amikacin, 5 (21.7%) to ci-
profloxacin, 2 (8.7%) to cefotaxime.The urine isolates produced the 
largest amount of pyocyanin (15.894 µg/ml). Pyaocyanin have shown 
antimicrobial activity against the following bacteria: Shigella spp., Sta-
phylococcus aureus and Staphylococcus epidermedis. Also, pyaocyanin 
can inhibit the following fungi and yeast: Aspergillus niger, Penicillium 
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Introduction
Pseudomonas aeruginosa is an opportunistic patho-
gen of human and can often lead to skin infections, 
otitis externa, septicemia, necrotizing pneumonia, 
burns and surgical wounds infections [1, 2]. 
P. aeruginosa is an opportunistic pathogen and it 
is a frequent cause of nosocomial infections, many 
of which are responsible for high mortality among 
hospitalized patients in intensive care units (ICU) 
and immunocompromised patients even when trea-
ted with appropriate antibiotics [1-2]. 
Pseudomonas aeruginosa produces a variety of 
cell-associated factors and toxin, some of which 
are responsible for its invasion and the severity of 
diseases. These include lipopolysaccharide (LPS), 
phospholipase, proteases, flagella, pili, exotoxins 
and pyocyanin [3-4]. 
Pyocyanin is a blue redox active, secondary 
metabolite,phenazine derivative that it exhibits a 
paradoxical pro-oxidant property [4]. A zwitterions 
that canenterbiological membranes, pyocyanin can 
directly accept electrons from reducing agents such 
asNADPH and reduced glutathione (Figure 1) and 
endure redox cycling using oxygen as an electron 
acceptor resulting in the generation of the reactive 
oxygen species (ROS), particularly hydrogen peroxi-
de, with resulting induction of oxidative stress and 
disturbance of intracellular redox homeostasis [5]. 
Therefore, the important mechanisms of pyocyanin 
to prokaryotic and eukaryotic cells are related to 
inhibition cellular respiration [6] 
Pseudomonas spp. are also capable of produ-
cing organic volatiles, whose in vitro antifungal na-
ture has been demonstrated against Phytophthora-
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spp., Rhizopus spp, Trichophyton mentagrophyte, Rhodotorula spp., 
Alternaria alternate, Trichophyton rubrum and Candida spp.
Conclusions: Antimicrobial activity of pyocyanin was more observed 
against Gram-positive than Gram-negative bacteria, but mostly similar 
against all fungi (molds and yeast). Cefotaxime was the most active 
antimicrobial drug against all P. aeruginosa isolates
Figure 1:  Chemical structure of reduced and oxidized forms of pyocyanin and mechanizm [5].
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vignae in cowpea [7]. These compounds inhibited 
sclerotic and ascosporic germination, and mycelial 
growth of Sclerotinia sclerotiorum, in vitro and in 
soil tests [8].
This study investigated the bioactivity of pyocya-
nin produced by fresh P. aeruginosa clinical isolates 
from patients against a variety of bacteria and fungi 
causing human infections.
Material and Methods
Bacterial strain isolation and identification
This study was performed from November,2016 
until May, 2017. A total of 23 P. aeruginosa isola-
tes were collected from urine, stool, diabetes leg, 
ear, burns and wounds infections of patients ad-
mitted to General Baqubah Hospital. The isolates 
were recovered from cultures on Pseudomonas 
agar, MaCconkey agar and blood agar. All isolates 
were identified as P. aeruginosa using gram-stain, 
blue-green pigmentation and biochemical charac-
terization [9].
Antibiotic susceptibility testing 
The antimicrobial susceptibility assay was performed 
on Mueller-Hinton agar using disc-diffusion method, 
and selection of antibiotics and growth inhibition 
zones were interpreted according to the Clinical La-
boratory Standards Institute [11]. The antimicrobial 
disks: piperacillin (100µg), cefotaxime (30µg), mero-
penem (10µg), aztreonem (30µg), amikacin (30µg) 
and ciprofloxacin (5µg) were obtained from (Mast 
Group, UK).
Pyocyanin Production
Nutrient broth was used for the extraction of pig-
ment from each P. aeruginosa isolate after incu-
bation for 2-3 days at 37°C. The change in color 
of the pigment to bluish green indicated pigment 
production [9].
Pyocyanin extraction
After the color media became bluish, 5 ml of each 
sample was centrifuged (3000rpm/10min) and 3ml 
of chloroform added to the supernatant and mixed 
until blue color is recovered. It was further confir-
med by adding 0.2 N HCl to the blue color solution 
which turned to red– pink [12].
Pyocyanin quantitative assay
The absorbance of each recovered solution was 
measured at 520 nm. Pyocyanin concentrations 
were expressed as micrograms of pigment per mi-
lliliterof culture and were determined by multiplying 
theoptical density at 520 nm by 17.072, according 
to the absorbance of pyocyanin at 520 nm in acid 
solution. [13].
Pyocyanin purification
0.4 M borate-NaOH buffer (pH= 10) was added to 
the pink solution until the color turned to blue and 
again extracted by chloroform. This step was repea-
ted 2 to 3 times resulting pyocyanin in chloroform 
in a clear blue solution. Finally pyocyanin powder 
was collected by evaporating the chloroform and 
weighted then rehydration by 1ml of sterilized dis-
tilled water [14].
Biological activity of recovered pyocyanin 
The assay of antibacterial and antifungal of pyo-
cyanin was carried out in well diffusion technique 
[15,16]. Wells with diameter size 6mm were made 
using Mueller-Hinton agar petri dish. Each one isola-
te of the following pathogenic bacteria were tested: 
Escherichia coli, Klebsiella pnemoniae, Shigella, Pro-
teus spp., Acinetobacter spp., Staphyllococcus au-
reus and Staphyllococcus epidermedis. pathogenic 
fungi and yeast namely Aspergillus niger, Penicillium 
spp., Rhizopus spp, Trichophyton mentagrophyte, 
Rhodotorula spp., Alternaria alternate, Trichophyton 
rubrum and Candida spp. The growth of each iso-
late was swabbed on the surface of nutrient agar 
and 100µl of pyocyanin solution (167mg/ml) were 
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added in to the well. Petri dishes were incubated at 
37ºC for 24-48 hours for bacteria and yeast, while 
kept for other fungi for up to one month. The in-
hibition zone in each well was measured by a ruler 
in mm unit to determine the biological activity of 
pyocyanin.
 
Results
A total of 23 P. aeruginosa isolates were investi-
gated for production of pyocyanin. Distribution of 
P. aeruginosa isolates according to clinical source 
are shown in Table 1. The majority of isolates were 
collected from era infections (30%), followed by 
wounds (22%), burns (17%), urine (13%) and each 
leg diabetes and stools (9%).
Suscptibility to antibiotics
The results of antimicrobial susceptibility test of 23 
P. aeruginosa isolates have shown high resistance 
rate (82.6 %) to piperacillin, followed by (43.5%) 
to aztreonem (34.8%), to meropenem (26.1%) to 
amikacin, (21.7%), to ciprofloxacin and (8.7%) to 
cefotaxime, respectively (Table 2). 
Pyocyanin extraction (quantitative assay)
A total of 6 clinical P. aeruginosa isolates were selec-
ted to extraction of pyocyanin according to intensity 
of blue pigmentation on tested agar.
Figure 2, shows the amount of pyocyanin obtai-
ned from each P. aeruginosa isolate according to 
their clinical source. The largest amount of pyocya-
nin (15.894 µg/ml) was recovered from one urine 
isolate. 
Figure 2:  Pyocyanin quantity (concentration (µg/
ml)=O.D. 520 nm ×17.072).
Wound isolate: W5, W4, W3; Burns isolates: B3, B4; Urine isolate: U1.
Biological activity of pyocyanin
The antimicrobial activity of purified pyocyanin 
(Needle-like crystal) at the concentration (167 mg/ 
ml) was monitored against different microorganisms 
as shown in Table 3.
Gram-positive such as Staphylococcus epidermi-
dis, Staphylococcus aureus; Gram-negative such as 
Escherichia coli,proteus spp., Klebsiella spp. and Aci-
netobacter spp.; molds such as and Yeast as Candid 
aalbicans. Results shown in table (3) indicate that 
pyocyanin shows high biological activity against 
all mentioned organisms, except against Klebsiella 
pneumonia, Acinetobacter spp., Proteus and Esche-
richia coli. 
Table 1.  Distribution of P. aeruginosa isolates accor-
ding to clinical source
Source
P. aeruginosa isolates
%
No (%) 
Ear 7 30
Wounds 5 22
Burns 4 17
Urine 3 13
Leg Diabetes 2 9
Stool 2 9
Total 23 100
Table 2.  Antimicrobial resistance profile of 23 P. 
aeruginosa isolates
Antibiotic
Resistant
%
Piperacillin 82.6
Aztreonem 43.5
Meropenem 34.8
Amikacin 26.1
Ciprofloxacin 21.7 
Cefotaxime 8.7
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Discussion
Pyocyanin is a blue pigment redox active produced 
by P. aeruginosa, The present study investigated 
production, purification, characterization and bioac-
tivity of pyocyanin pigments produced by local cli-
nical P. aeruginosa isolates. The results have shown 
that P. aeruginosa isolates were most commonly 
associated with ear infection (30%) followed by 
other body sites in our region of Iraq. Many studies 
carried out in Iraq and other countries demonstra-
ted wide spread of P. aeruginosa isolates in clinical 
specimens. A study of Abbas in Baqubah/Iraq, has 
found that P. aeruginosa first commonly isolated 
from burns cases (18.18%), followed by ear (11.6%), 
urine (10.8%)and wounds (6.25%) [17]. While the 
study of Al-Imari in Baghdad/Iraq, has reported the 
incidence P. aeruginosa isolates from certain clini-
cal specimens as follow: urine (22.4%), ear (18.4%), 
sputum (16.3%), burns (14.3%) and wounds (12.3%) 
[18]. El fouly and coworkers in Cairo, Egypt found 
that P. aeruginosa was the most common cause of 
urinary tract infection (12.5%), followed by burns 
(10%) and sputum (9%) [19]. The reasons of va-
riations in the occurrence rates of P. aeruginosa 
infections may be due to underlining diseases of 
investigated patients, virulence factors and the local 
antimicrobial resistance of the organism, and other 
health conditions [2]. In addition, P. aeruginosa is 
able to act as opportunistic pathogens in human 
and patients with weakened immune systems, and 
especially during hospitalization in intensive care 
units [1-2].
The present study indicated that P. aeruginosa 
isolates have the highst resistant rate to piperacillin 
(82.6%) and less to other antimicrobial agents as 
shown in Table 2. The study of Al- Alkhozai and 
Alkabei in Diwanyia, Iraq, reported similar resistance 
rate in P.aeruginosa isolates to piperacillin (94%) and 
high resistance rate to aztreonem (88.5%) [20]. This 
study found a resistance rate of 43.5% to aztreo-
nem, whereas the study in Baqubah/Iraq reported 
very low resistance rate of 5% to aztreonem among 
P. aeruginosa isolates [17]. The study of Ameen and 
coworkers in Pakistan, have found that P. aerugino-
sa resistant to aztreonem was (86.1%) [21]
It is well established that the development of 
resistance of P. aeruginosa to antibiotics is increa-
sing locally and globally due to the overuse of an-
tibiotics [1]. There are various multiple mechanisms 
contribute to developing antimicrobial resistance in 
P. aeruginosa, including active efflux, acquisition of 
various beta-lactamases,decrease outer membrane 
permeability and target modification [22-23]. The-
refore, distinguishing the trends in resistance of P. 
aeruginosa becomes important for choosing the 
right antibiotic [24]. 
The production of pyocyanin is exclusive to P. 
aeruginosa, and its production can be improved by 
Table 3.  Diameter of antimicrobial activity of pyo-
cyanin to various tested microorganisms. 
Microorganism Properties
Inhibition 
zone (mm) 
Shigella spp. Gram negative 25
Staphylococcus epidermedis Gram positive 23
Staphylococcus aureus Gram positive 23
Klebsiella pneumonia Gram negative None
Acinetobacter spp. Gram negative None
Proteus spp. Gram negative None
Escherichia coli Gram negative None
Penicillium spp. Mold
25 
(inhibition 
of spore 
formation)*
Aspergillusniger Mold 25 
Aspergillus spp. Mold 23 
Trichophytonmentagrophyte Mold 23 
Trichophytonrubrum Mold 23 
Rhizopus spp.1 Mold 23 
Alternaria alternate Mold 23 
Rhodotorula spp. Mold 23 
Rhizopus spp.2 Mold 10 
Candida spp.1 Yeast 20
Candida spp.2 Yeast 17
*: Apply for all tested fungi.
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culture strains on King’s A medium which has potas-
sium and magnesium salts in appropriate concen-
tration to defeat fluorescein production (pyoverdine) 
[2]. Pyocyanin is blue color in alkaline and neutral 
pH while red color in acid pH. Any change in the 
pH may affect the color of pyocyanin [25]. In addi-
tion, the variation in pyocyanin production among 
different strains could be due to various factors such 
as lighting conditions. It has been reported that the 
concentration of pyocyanin was reduced under cer-
tain lighting conditions. This decrease was depen-
dent on both the light intensity and wavelength 
and occurred with light in the ultraviolet and violet 
region of the spectrum [26-27].
The present study has demonstrated that pyo-
cyanin production by all investigated clinical isolates 
had antimicrobial activity against Gram-positive Sta-
phyloccocus spp. more than gram negative bacteria 
and to some extent against yeast such Candida spp. 
and filamentous fungi. This result is in agreement 
with those results of Makarand et al. (2007) which 
have reported that phenazine antibiotic (chemical 
substance similar to pyocyanin) have antimicrobial 
activity against strains of Bacillus subtilis and Can-
dida albicans [28].
The study of El fouly in Egypt, found that P. aeru-
ginosa isolated from human urine sample produced 
more pyocyanin concentration than isolates from 
rice cultivated soil (production titer was 6.3 and 5.9 
mg/ml, respectively) [19], While Ra’oof and Latif, in 
Iraq, has detected that the P. aeruginosa isolate 
from sputum produced the largest amount of pyo-
cyanin (12.069 µg/ml) [29]. The study of Charyulu et 
al. (2009), has shown that the secondary metabolite 
from Pseudomonas which played a significant role 
in lyses the pathogenic bacterial including MRSA 
strains [30]. Also, the Sudhakar et al. (2013) showed 
different antimicrobial activity against E. coli, S. au-
reus, Proteus sp., and Klebsiella spp. [31], while the 
study Karpagam et al., (2013) found the pigment 
produced by P. aeruginosa has antifungal activity 
against Candida sp. and Cryptococcus neoformans 
[32]. 
In conclusion, pyocyanin produced by clinical P. 
aeruginosa isolates has various spectrum of antibac-
terial and antifungal activity against certain Gram-
positive and Gram-negative bacteria, Candida spp. 
and filamentous in vitro. 
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